Kamil Ali-Jackson, Chief Legal Officer at Aclaris Therapeutics, Inc. (ACRS), sold 90,238 shares at $22.31 ($2.0M) on 2021-06-02, disclosed to the SEC on 2021-06-02.
Open-market sale of $2.0M ACRS by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.72 | 9,746 | $221K | 11.1% |
| 2 | $22.72 | 9,746 | $221K | 11.1% |
| 3 | $23.57 | 5,254 | $124K | 6.2% |
| 4 | $23.57 | 5,254 | $124K | 6.2% |
| 5 | $21.50 | 12,483 | $268K | 13.5% |
| 6 | $21.50 | 12,483 |
| $268K |
| 13.5% |
| 7 | $21.51 | 12,732 | $274K | 13.7% |
| 8 | $21.51 | 12,732 | $274K | 13.7% |
| 9 | $22.31 | 2,387 | $53K | 2.7% |
| 10 | $22.31 | 2,387 | $53K | 2.7% |
| 11 | $22.32 | 2,517 | $56K | 2.8% |
| 12 | $22.32 | 2,517 | $56K | 2.8% |
| Total | $22.10 avg | 90,238 | $2.0M | 100% |
| Filing → |
| PDSB | BUY | 2021-06-17 | $100K | — | Filing → |
| ACRS | SELL | 2021-06-04 | $417K | — | Filing → |
| ACRS | SELL | 2021-05-07 | $907K | — | Filing → |